Work

Trial Protocol S1 from Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial

Year: 2025

Type: other

Abstract: Clinical Trial Protocol

DOI: 10.1158/1078-0432.29052835

Authors: Sung Hee Lim, Minae An, Hyuk Lee, You Jeong Heo, Byung-Hoon Min, Arnav Mehta, Samuel Wright, Kyoung-Mee Kim, Seung Tae Kim, Samuel J. Klempner, Jeeyun Lee

Institutions: Samsung Medical Center, Sungkyunkwan University

Language: English

Topic: Gastric Cancer Management and Outcomes

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4410339098

Cites: 7

Cited by:

Related to: 10